The new drug application (NDA) seeks approval of dasatinib to treat chronic myelogenous leukemia, as well as Philadelphia chromosome-positive (Ph+) acute lymphoblastic leukemia, in adult patients with resistance
Besides the nasal spray, ciclesonide is the active substance of an inhaled corticosteroid that is already approved in 35 countries worldwide for the treatment of persistent asthma. In
This nine-center clinical trial involves 20 patients who received a single injection of one of two doses of AdPEDF. Study participants will be evaluated at three and twelve
Antisoma will choose up to three compounds from the EcoBiotics portfolio to evaluate during the next year. If these evaluations yield positive results, Antisoma will have rights to
Under the terms of the ten-year agreement, Cipla will be responsible for the manufacturing and supply of the drug using Akorn’s formulation, and Akorn will be responsible for
The filing allows Quigley Pharma, a wholly owned subsidiary of Quigley Corporation, to begin human clinical trials following a 30-day review period. If the FDA has no further
Baxter initiated the verification study to address the rising public concern over the spread of the H5N1 virus outside of Asia, the recent demonstration that the H5N1 virus
The NIH’s Chemical Genomics Center (NCGC) was created as part of an NIH initiative to discover novel compounds that can be used to investigate fundamental biological questions or
The Anti-Infective Drugs Advisory Committee (AIDAC) voted that there was substantial evidence of safety and efficacy of Cubicin (daptomycin for injection) in the treatment of S. aureus bacteremia
Myogen has licensed commercialization rights for ambrisentan, a selective endothelin receptor antagonist (ERA) currently in phase III development, to GlaxoSmithKline in all territories outside of the US. Filing
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.